Biology and prognostic factors

Poster Discussion
Chairs: A. Meert (Brussels, Belgium), M. Paesmans (Brussels, Belgium)

Effect of comorbidity on the prognosis of non-small cell lung cancer A. Ozgun, E. Kunter, G. Kandemir, O. Turken, B. Karagoz, O. Bilgi (Istanbul, Turkey)
Role of Charlson cormobidity index in the advanced non small cell lung cancer H. Ooi, Y. T. Wang, Y. H. Liu, T. C. Hsia, C. M. Shih, W. H. Hsu (Taichung, Taiwan, Province Of China)
Epidemiology of surgically treated lung cancer in Lorraine, France: 1988-2005. The CRB cohort study F. Vlastos, F. Alla, J. Siat, G. Grosdidier, N. Winbreck, J. M. Vignaud, N. Martinet, Y. Martinet (Athens, Greece; Nancy, France)
Neuroendocrine differentiation is an independent prognostic factor in chemotherapy-treated non-small cell lung cancer M. Petrovic, I. Tomic, S. Ilic, I. Jevtovic, I. Cekerevac, L. Novkovic, S. Mojsilovic (Kragujevac, Belgrade, Serbia And Montenegro)
The predictive value of neuroendocrine markers for response to chemotherapy and survival in patients with non-small cell lung M. Petrovic, I. Tomic, I. Jevtovic, Z. Lazic, I. Cekerevac, S. Mojsilovic, L. Novkovic (Kragujevac, Belgrade, Serbia And Montenegro)
Lung cancer and hemostasis – the impact of subclinical thrombotic manifestations upon the prognosis: a prospective hospital study B. Escarguel, F. Giauffret, V. Thomas, L. Chollet, D. D‘Amore, C. Audigier-Valette, L. Marqueste (Toulon, France)
Prognostic impact of lymphangiogenesis and lymphatic invasion (CD105 expression) in small cell lung carcinomas G. Hardavella, E. Arkoumani, Y. Dalavanga, M. Vassiliou, D. Stefanou, S. H. Constantopoulos (Ioannina, Greece)
Expression of vascular endothelial growth factor (VEGF) and association with lymphangiogenesis in non small cell (NSCLC) and small cell lung carcinomas (SCLC) G. Hardavella, E. Arkoumani, Y. Dalavanga, M. Vassiliou, D. Stefanou, S. H. Constantopoulos (Ioannina, Greece)
The neoadjuvant therapy of NSCLC down-regulates serum levels of growth factors (VEGF, bFGF, TGF-beta) with no effect on apoptosis (CD95L) and local tumour invasiveness markers (TIMP-1) J. Chorostowska-Wynimko, J. Zaleska, M. Chabowski, A. Stepniewska, J. Zych, P. Rudzinski, R. Langfort, T. Orlowski, K. Roszkowski (Warsaw, Poland)
Immunohistochemical studies of COX-2, MMP-9, p53 and VEGF in non-small-cell lung cancer, specifically squamous cell carcinoma and adenocarcinoma I. W. Park, J. W. Shin, J. C. Choi, S. Y. Lim, J. Y. Kim, B. W. Choi, J. H. Yoo (Seoul, Republic Of Korea)
Telomerase activity in transthoracic fine needle biopsy specimens as a prognostic factor of survival in patients with non-small cell lung cancer (NSCLC) treated surgically or nonsurgically T. Targowski, K. Jahnz-Rozyk, T. Szkoda, T. Plusa, J. Mierzejewska, N. Qandil, C. Jochymski, S. From, P. Grabowska, P. Janda (Warsaw, Otwock, Poland)
Prognostic value of apoptotic index (AI) considered jointly with cell cycle regulators in non-small cell lung cancer (NSCLC) D. Dworakowska, A. Karmolinski, E. Jassem, J. Jassem, M. Lapinski, D. Tomaszewski, K. Jaskiewicz, S. Yla-Herttuala, J. Skokowski, E. Czestochowska, K. Sworczak (Gdansk, Poland; Kuopio, Finland)
Anti-tumour effects of coculture of dendritic cells with cytokine-induced killer cells against lung cancer in vitro and in vivo J. A. Huang, X. J. Yang, W. Lei, Y. B. Zhu, X. G. Zhang (Suzhou, China)
Targeting gene of insulin-like growth factor type I (IGF-I) on in vitro model of A549 cell line with triple-helix approach. Perspectives of gene therapy in non-small cell lung (NSCLC) cancer P. Kopinski, J. Tujakowski, K. Bartczak, J. Golinska, A. Szpechcinski, P. Jarocki (Bydgoszcz, Krakow, Poland)
Secretory leukocyte proteinase inhibitor in lung cancer: an immunohistochemical and serological study K. W. van Kralingen, S. Wassink, J. T. Annema, L. N. A. Willems, I. M. Bajema, A. van Schadewijk, P. S. Hiemstra, K. F. Rabe (Leiden, Netherlands)
Angiopoietin-2 as a prognosticator of lung cancer J. H. Park, H. N. Lee, K. S. Lee, Y. J. Oh, S. S. Sheen, Y. H. Choi, K. J. Park, S. C. Hwang (Suwon, Republic Of Korea)
The expression rate of hTERT mRNA of bronchial washing in lung cancer patients K. H. Lee, K. C. Shin, J. H. Chung, J. W. Park, Y. J. Jeon, C. H. Jeon, S. C. Lee, T. H. Jung (Daegu, Republic Of Korea)
Clinical significance of circulating KL-6/MUC1 carrying selectin ligands in patients with lung adenocarcinoma J. Inata, N. Hattori, S. Ohshimo, T. Nakashima, M. Doi, H. Hamada, A. Yokoyama, N. Kohno (Hiroshima, Ehime, Japan)
Anticancer and cancer prevention effects of toona sinensis leaf extract in human NSCLC cell J. Y. Hung, C. C. Sheu, J. R. Tsai, I. W. Chong, J. J. Hwang, H. K. Hsu, M. S. Huang (Kaohsiung, Taiwan, Province Of China)
Adenoviral transduction of MRP-1/CD9 and KAI-1/CD82 inhibits lymph node metastasis in orthotopic lung cancer model N. Hattori, T. Takeda, M. Miyake, N. Kohno (Hiroshima, Kobe, Osaka, Japan)